Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Genitourinary 2Thoracic 1Sarcoma 1Gastrointestinal 1Classical hematology 1

Conditions

Febrile Neutropenia 8Neoplasms 5Anemia, Refractory, with Excess of Blasts 5Leukemia, Myeloid, Acute 4Anemia 4Venous Thromboembolism 3Thrombocytopenia 3Hematologic Neoplasms 3Fanconi Anemia 2Congenital Bone Marrow Failure Syndromes 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Anemia, Iron-Deficiency 2Uterine Cervical Neoplasms 1Thrombophilia 1Stomatitis 1Stomach Neoplasms 1Scleroderma, Systemic 1Sarcoma 1Recurrence 1Radiation Injuries 1Pulmonary Blastoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Periodontitis 1Neutropenia 1Neoplasms, Plasma Cell 1Myositis 1Myeloproliferative Disorders 1Myasthenia Gravis 1Multiple Myeloma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Radiation Injuries × Classical hematology × Clear all
NCT06745219 2024-12-20

Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer

Peking University Cancer Hospital & Institute

Phase 2 Not yet recruiting
30 enrolled
Classical hematologyGynecologic

Uterine Cervical Neoplasms, Radiation Injuries, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡